Check out our most popular compounded medications! Get Started
Nitrofurazone 0.02%/Phenylephrine HCl 0.25% Nasal Solution is a specialized liquid formulation designed for nasal use. It is intended for the treatment of conditions such as rhinitis, sinusitis, allergic rhinitis, nasal congestion, and rhinorrhea. The medication is typically administered using a dropper or other suitable nasal delivery device.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to present the Nitrofurazone 0.02%/Phenylephrine HCl 0.25% Nasal Solution, a specialized compounded formulation. This unique blend is designed to address various nasal conditions such as sinusitis, rhinitis, and nasal congestion. The Nitrofurazone 0.02%/Phenylephrine HCl 0.25% Nasal Solution is a liquid formulation specifically formulated for nasal use. It is intended for the administration of medication, irrigation, or moisturization to the nasal cavity, providing targeted treatment for nasal conditions, allergies, congestion, or post-nasal drip. It is typically administered using a dropper or other appropriate nasal delivery device.
The Nitrofurazone component is an antibacterial agent that aids in reducing inflammation and swelling in the nasal passages. On the other hand, Phenylephrine HCl serves as a decongestant that assists in alleviating nasal congestion. The combination of these two active ingredients offers relief from the symptoms of sinusitis, rhinitis, and nasal congestion.
It is conveniently available in a nasal spray bottle, making it easy to administer.
If you have any inquiries about this formulation or how it can help manage your nasal condition, please do not hesitate to contact us at Bayview Pharmacy. We are dedicated to helping you find the most suitable solution for your health needs.
Nitrofurazone 0.02%/Phenylephrine HCl 0.25% Nasal Solution is a specially formulated liquid medication designed for nasal administration. It is primarily used for the treatment of rhinitis, sinusitis, and other nasal and sinus infections.
Patients with a known hypersensitivity to any of the components of this formulation should refrain from using it. It is important to avoid contact with eyes and mucous membranes while using this solution. In case of accidental contact, the affected area should be thoroughly rinsed with water.
Patients are advised not to use this formulation for more than 7 days without consulting a healthcare provider. Prolonged use without medical supervision may lead to potential health risks.
Concomitant use of this nasal solution with other nasal decongestants, antihistamines, or other medications may increase the risk of adverse effects. Therefore, it is crucial for patients to inform their healthcare provider about any other medications they are currently taking before starting this treatment.
Furthermore, this formulation should not be used by pregnant or breastfeeding women unless advised by a healthcare provider. The potential risks and benefits should be thoroughly discussed with a healthcare professional before use.
If you have any questions or concerns about the use of Nitrofurazone 0.02%/Phenylephrine HCl 0.25% Nasal Solution, please do not hesitate to reach out to your healthcare provider for further guidance.
Nitrofurazone 0.02%/Phenylephrine HCl 0.25% Nasal Solution is a specially compounded liquid formulation designed for nasal administration. This combination medication is primarily used to alleviate nasal congestion and inflammation that may be caused by allergies, colds, or other respiratory conditions. The two active ingredients in this formulation are nitrofurazone, an antibiotic, and phenylephrine hydrochloride, a decongestant.
Nitrofurazone functions by eliminating bacteria that cause infections, thereby helping to reduce inflammation. On the other hand, phenylephrine hydrochloride works by reducing swelling and congestion in the nasal passages, making it easier for the patient to breathe. This targeted treatment provides relief for a variety of nasal conditions, including allergies, congestion, and post-nasal drip.
When using Nitrofurazone 0.02%/Phenylephrine HCl 0.25% Nasal Solution, it is crucial to adhere to the instructions provided by your healthcare provider or pharmacist. The typical dosage is one or two drops in each nostril, administered up to four times daily. It is important not to exceed the recommended dosage, as this could potentially lead to serious side effects. Additionally, care should be taken to avoid contact with the eyes to prevent irritation.
This formulation is not intended for prolonged use. It should not be used for more than five consecutive days, as this could potentially lead to a rebound effect, where symptoms return or worsen after discontinuing the medication. If symptoms persist beyond five days, it is essential to consult with your healthcare provider or pharmacist for further guidance.
If you have any questions or concerns about this formulation or its administration, do not hesitate to contact your healthcare provider or pharmacist. They can provide you with the necessary information and guidance to ensure you are using the medication safely and effectively.
This is a liquid formulation specifically designed for nasal use. It is intended for the administration of medication, irrigation, or moisturization to the nasal cavity. It provides targeted treatment for nasal conditions, allergies, congestion, or post-nasal drip. It is typically administered using a dropper or other appropriate nasal delivery device.
The active ingredients in this nasal solution are Nitrofurazone and Phenylephrine HCl.
Nitrofurazone is an antibiotic that helps to prevent or treat bacterial infections.
Phenylephrine HCl is a decongestant that shrinks blood vessels in the nasal passages. This helps to reduce swelling and congestion.
This nasal solution is typically administered using a dropper or other appropriate nasal delivery device. It is intended for nasal use only.
This nasal solution can provide targeted treatment for nasal conditions, allergies, congestion, or post-nasal drip.
Yes, this nasal solution can be used for the administration of medication, irrigation, or moisturization to the nasal cavity.
Before using this nasal solution, it is important to consult with a healthcare provider. They can provide information about potential risks and benefits, and determine whether this product is safe and appropriate for individual use.
If you experience any side effects, stop using the product and consult with a healthcare provider immediately.
Store this nasal solution in a cool, dry place, away from direct sunlight. Always keep it out of reach of children.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Inhale into nostril(s)
